Wyeth Research

Pharmacopeia to Present At the BMO Capital Markets 8th Annual Focus On Healthcare Conference

primenewswire.com     yesterday   2 related          

PRINCETON, N.J., July 23, 2008 (PRIME NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced that Dr. Joseph A. Mollica, Chairman of the...                

Wyeth Q2 2008 Earnings Call Transcript (at Seeking Alpha)

yahoo.com     17 hrs ago   29 related          

posted on: July 23, 2008 | about stocks: WYE Executives Gregory Norden - On the call with me today are Bernard Poussot, Chairman, President and Chief Executive Officer of Wyeth; Joe Mahady, President of Wyeth Pharmaceuticals...                

Six countries across Europe and the Middle East recently announced the inclusion of the 7-valent...

zawya.com     yesterday   1 related          

After being labeled by the WHO as the number one cause of vaccine-preventable death among children Maidenhead, 23 July 2008 - Ministries of Health in Cyprus, Hungary, the Kingdom of Bahrain, Republic of Ireland, Slovak Republic...                

Pharmed owners face fraud charge

miamiherald.com     yesterday   1 related          

The de Céspedes brothers, who owned Pharmed, were charged with healthcare fraud and tax evasion. In two separate cases spawned by unrelated investigations, the brothers who owned the medical supply distributor Pharmed were...                

Pharmed Founders, the Cespedes Brothers, Charged with Fraud

hispanicbusiness.com     yesterday   7 related          

Carlos and Jorge de Cespedes, founders of Pharmed, once one of the largest Hispanic-owned businesses in the country, were charged Tuesday in federal court with healthcare-related wire fraud and income tax evasion. They're...                

Exelixis Announces August 5 Webcast of Its Second Quarter 2008 Financial Results and Business...

ad-hoc-news.de     yesterday   3 related          

Exelixis Announces August 5 Webcast of Its Second Quarter 2008 Financial Results and Business Update Conference Call Exelixis Announces August 5 Webcast of Its Second Quarter 2008 Financial Results and Business Update...                

Elan and Wyeth Announce Webcast to Discuss Bapineuzumab Phase 2 Clinical Trial Results

webwire.com     yesterday   8 related          

Dublin, Ireland and Madison, NJ . —Elan Corporation, plc (NYSE: ELN) and Wyeth (NYSE: WYE) today announced that the companies will hold a webcast at 6:00 p.m. Central Daylight Time (7:00 p.m. Eastern ... [WebWire - Tuesday,...                

Infinity Announces the Addition of Two New Board Members and Leadership Promotions

primenewswire.com     yesterday   2 related          

CAMBRIDGE, Mass., July 22, 2008 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced the appointment of two new members to its Board of...                

Wyeth Pearl River Facility Earns OSHA VPP Star; 2,000th Workplace Recognized in U.S. (PR Newswire)

yahoo.com     Jul 21, 2008   5 related          

Wyeth announced today that its manufacturing and research facility in Pearl River, N.Y., has earned the highest recognition for workplace safety and health from the U.S. Department of Labor's Occupational Safety and Health...                

Exelixis Initiates Phase 3 Trial of XL184 in Medullary Thyroid Cancer

genengnews.com     Jul 21, 2008   9 related          

News source: Business Wire Exelixis, Inc. announced today that the phase 3 registration trial of XL184 as a potential treatment for medullary thyroid cancer (MTC) has been initiated. "We are thrilled that the pivotal trial for...                

1 2 3 4 5 next »